Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Moderna Therapeutics

Explore full profile

Provides a real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease

Cambridge, United StatesFounded 2010Biotech & Life Sciences
Valuation $18B Market cap · Aug/2026
Revenue $2.10B Latest reported FY

At a glance

Status
Listed
Founded
2010
Headquarters
Cambridge, United States
Listing
IPO 2018
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News Moderna raises $2.6B convertible note as it pivots to cancer mRNA Sep 24, 2026 Analysis Moderna vs BioNTech Sep 11, 2026 News Moderna to raise $2B in convertible notes after cancer vaccine rally Aug 27, 2026 News Moderna and Merck's cancer vaccine intismeran hits both endpoints in Phase 3 melanoma trial Aug 19, 2026

Investors

20 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later19 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 6,240 incl. 57 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 20 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 12 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 12 startups shown

Former Moderna Therapeutics employees who went on to found companies, sorted by Dealroom signal score.

Lila SciencesEst. 2022
JFJacob FealaUnited States
Signal score97
Fortitude BiomedicinesEst. 2025
Jesse ChenUnited States
Signal score91
Dash BioEst. 2024
ATAnder TallettUnited States
Signal score89
Plasana MedicalEst. 2022
Sébastien BalasFrance
Signal score87
Matter NeuroscienceEst. 2019
Axel BouchonUnited States
Signal score86
7 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
35 countries with
team presence
🇺🇸 United States81%
🇵🇱 Poland3.2%
🇨🇭 Switzerland3.1%
🇬🇧 United Kingdom2.7%
🇨🇦 Canada2.3%
Top 5 of 35 shown
Web traffic by country
170K monthly visits
across markets
🇺🇸 United States45%
🇬🇧 United Kingdom8.7%
🇮🇳 India6.4%
🇨🇦 Canada4.5%
🏳️ Korea3.3%
Top 5 markets shown

Patents

Estimated portfolio value
$189M

234 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Moderna Therapeutics was the backer or acquirer, 2014–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Moderna Therapeutics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Moderna Therapeutics's portfolio, mapped.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Moderna Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Moderna Therapeutics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles